Top Stories

Top Stories Recent News

What's Going On With Galaxy Digital (GLXY) Stock Wednesday?
What's Going On With Galaxy Digital (GLXY) Stock Wednesday?
Galaxy Digital Inc (NASDAQ:GLXY) shares are trading lower on Wednesday afternoon, caught in a broad market sell-off.
Rigetti Computing (RGTI) Stock Is Falling Sharply: What's Going On?
Rigetti Computing (RGTI) Stock Is Falling Sharply: What's Going On?
Shares of Rigetti Computing and other quantum computing stocks are trading lower Wednesday afternoon, caught in a broader market downturn.
Halliburton Targets Higher Returns With Leaner Spending: Analysts
Halliburton Targets Higher Returns With Leaner Spending: Analysts
Halliburton reports strong Q3 results, upgraded by RBC Capital Markets analysts to Outperform with a $31 price target.
Coca-Cola's 'Best In Class' Strategy Spurs Margin Optimism: Analyst
Coca-Cola's 'Best In Class' Strategy Spurs Margin Optimism: Analyst
Coca-Cola highlights "best in class" strategy, Zero Sugar momentum; BofA's Galbo sees FX tailwinds, Africa refranchising margin gains, steady growth.
Chubb Ramps Up Buybacks As Management Sees Stock Undervalued
Chubb Ramps Up Buybacks As Management Sees Stock Undervalued
Chubb Ltd. (CB) announced strong Q3 results, beating expectations on key metrics. Analysts reaffirm bullish outlook with $325 price target.
Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data?
Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data?
Terns Pharmaceuticals announces 12-week Phase 2 results for oral obesity drug TERN-601, showing up to 4.6% weight loss but reporting cases of drug-induced liver injury.
Novartis Cosentyx Trial Shows Efficacy In Patients With Stiff Joints And Muscle Pain
Novartis Cosentyx Trial Shows Efficacy In Patients With Stiff Joints And Muscle Pain
Novartis' Cosentyx Phase 3 REPLENISH trial for polymyalgia rheumatica met primary and secondary endpoints, showing significant sustained remission.
Tesla's Reality Check: Can EV ETFs Regain Power After Earnings?
Tesla's Reality Check: Can EV ETFs Regain Power After Earnings?
Tesla's Q3 earnings will test the pulse of EV ETFs as recalls and price cuts weigh on sentiment and investors seek steadier clean-energy plays.
Lowe's Eyes Growth As Housing Market Nears Turning Point
Lowe's Eyes Growth As Housing Market Nears Turning Point
Lowe's Co. (LOW) is growing in the home improvement market with acquisitions and Pro platform, despite challenges.
Vertiv Thrives In AI Era With Strong Backlog, Analyst Says
Vertiv Thrives In AI Era With Strong Backlog, Analyst Says
Vertiv Holdings Co (NYSE: VRT) reported outstanding quarter with record orders and raised full-year guidance. Goldman Sachs reiterates Buy.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved